CNTB
Morgan Stanley’s Connect Biopharma CNTB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98 | Buy |
+100
| New | +$98 | ﹤0.01% | 7652 |
|
|
2024
Q3 | – | Sell |
-3,568
| Closed | -$5.42K | – | 7944 |
|
|
2024
Q2 | $5.42K | Buy |
+3,568
| New | +$5.42K | ﹤0.01% | 6829 |
|
|
2023
Q4 | – | Sell |
-1
| Closed | -$1 | – | 7840 |
|
|
2023
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 7600 |
|
|
2023
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 7643 |
|
|
2023
Q1 | $1 | Sell |
1
-358
| -100% | -$358 | ﹤0.01% | 7701 |
|
|
2022
Q4 | $311 | Sell |
359
-7,732
| -96% | -$6.7K | ﹤0.01% | 7604 |
|
|
2022
Q3 | $10K | Sell |
8,091
-64
| -0.8% | -$79 | ﹤0.01% | 7062 |
|
|
2022
Q2 | $7K | Sell |
8,155
-681
| -8% | -$585 | ﹤0.01% | 7309 |
|
|
2022
Q1 | $27K | Buy |
8,836
+3,537
| +67% | +$10.8K | ﹤0.01% | 7005 |
|
|
2021
Q4 | $27K | Buy |
+5,299
| New | +$27K | ﹤0.01% | 7090 |
|
|
2021
Q3 | – | Sell |
-1,197
| Closed | -$23K | – | 7943 |
|
|
2021
Q2 | $23K | Buy |
+1,197
| New | +$23K | ﹤0.01% | 6954 |
|